We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Eli Lilly, McDonald's, TOTAL, American Express and Southern Copper
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 9, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Company (LLY - Free Report) , McDonald's Corporation (MCD - Free Report) , TOTAL SE , American Express Company (AXP - Free Report) and Southern Copper Corporation (SCCO - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Eli Lilly, McDonald's and TOTAL
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, McDonald's and TOTAL. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Eli Lilly shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+52.5% vs. +10.5%), reflecting the company's favorable revenue growth profile as a result of higher demand for drugs like Trulicity, Taltz, and others.
The company has some intriguing pipeline assets for cancer, diabetes and Alzheimer's that provide a boost to its growth potential beyond 2025. It also received rapid emergency approvals for bamlanivimab and Olumiant for COVID-19 in 2020. It is regularly adding promising new pipeline assets through business development deals.
However, generic competition for several drugs, rising pricing pressure in the United States mainly on key drug Trulicity, and price cuts in some international markets like China, Japan and Europe are some top-line headwinds.
Shares of McDonald's have lost -3.8% in the last six months against the Zacks Restaurants industry's gain of +9%. The Zacks analyst, however, believes that the company's increased focus on drive-thru, delivery & take-away are likely to benefit the company going forward.
In order to boost its digital offerings across drive thru, takeaway, delivery, curbside pick-up and dine-in categories, the company is currently working on a new digital experience growth engine, "MyMcDonald's". Additionally, it is making every effort to drive growth in international markets as well.
Although the company has reopened most of its restaurants, it is likely to witness dismal traffic due the social distancing protocols. Moreover, shutdown of dine-in in several markets will continue to hurt the company's performance.
TOTAL shares have gained +10% over the past three months against the Zacks Integrated International Oil industry's gain of +22.5%. The Zacks analyst believes that TOTAL is gaining from new startups, its LNG portfolio and expanding upstream portfolios that have exposure to fast-growing hydrocarbon producing regions.
Its joint venture in the United States and acquisition of an interest in the renewable business in India are in sync with the goal of becoming net zero by 2050. Streamlining of its portfolio and ongoing investments will strengthen operations, thereby boosting the company's performance.
It remains exposed to acquisition-related risks as these assets contribute a sizable volume to production. TOTAL's operations in some politically-troubled regions and increasing competition might affect profitability.
Other noteworthy reports we are featuring today include American Express and Southern Copper.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Eli Lilly, McDonald's, TOTAL, American Express and Southern Copper
For Immediate Release
Chicago, IL – March 9, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly and Company (LLY - Free Report) , McDonald's Corporation (MCD - Free Report) , TOTAL SE , American Express Company (AXP - Free Report) and Southern Copper Corporation (SCCO - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Eli Lilly, McDonald's and TOTAL
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, McDonald's and TOTAL. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Eli Lilly shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+52.5% vs. +10.5%), reflecting the company's favorable revenue growth profile as a result of higher demand for drugs like Trulicity, Taltz, and others.
The company has some intriguing pipeline assets for cancer, diabetes and Alzheimer's that provide a boost to its growth potential beyond 2025. It also received rapid emergency approvals for bamlanivimab and Olumiant for COVID-19 in 2020. It is regularly adding promising new pipeline assets through business development deals.
However, generic competition for several drugs, rising pricing pressure in the United States mainly on key drug Trulicity, and price cuts in some international markets like China, Japan and Europe are some top-line headwinds.
(You can read the full research report on Eli Lilly here >>>)
Shares of McDonald's have lost -3.8% in the last six months against the Zacks Restaurants industry's gain of +9%. The Zacks analyst, however, believes that the company's increased focus on drive-thru, delivery & take-away are likely to benefit the company going forward.
In order to boost its digital offerings across drive thru, takeaway, delivery, curbside pick-up and dine-in categories, the company is currently working on a new digital experience growth engine, "MyMcDonald's". Additionally, it is making every effort to drive growth in international markets as well.
Although the company has reopened most of its restaurants, it is likely to witness dismal traffic due the social distancing protocols. Moreover, shutdown of dine-in in several markets will continue to hurt the company's performance.
(You can read the full research report on McDonald's here >>>)
TOTAL shares have gained +10% over the past three months against the Zacks Integrated International Oil industry's gain of +22.5%. The Zacks analyst believes that TOTAL is gaining from new startups, its LNG portfolio and expanding upstream portfolios that have exposure to fast-growing hydrocarbon producing regions.
Its joint venture in the United States and acquisition of an interest in the renewable business in India are in sync with the goal of becoming net zero by 2050. Streamlining of its portfolio and ongoing investments will strengthen operations, thereby boosting the company's performance.
It remains exposed to acquisition-related risks as these assets contribute a sizable volume to production. TOTAL's operations in some politically-troubled regions and increasing competition might affect profitability.
(You can read the full research report on TOTAL here >>>)
Other noteworthy reports we are featuring today include American Express and Southern Copper.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.